Inside Precision Medicine September 5, 2024
Can AI-generated, HIPAA-compliant monthly reports on disease progression with proactive recommendations move the needle on Parkinson’s care?
While working on a “secret project” at Google Life Sciences (before it had been rebranded to Verily), Brian Pepin was struck with a question:
Why aren’t there analogous devices to glucose monitors for neurological diseases like Parkinson’s?
“At least in terms of the data, science, and symptoms, Parkinson’s is a more complex disease than diabetes, where you have nominally fewer kinds of inputs and outputs—you’re tracking blood glucose, or maybe you’re looking at A1C,” Pepin told Inside Precision Medicine. “But in Parkinson’s, you’re looking at multiple types of symptoms, including tremors and dyskinesia.”
That question inspired Pepin to leave the tech giant six...
Today's Sponsors
Today's Sponsor